Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft.

Petrangolini, G

Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft. [electronic resource] - British journal of cancer Apr 2004 - 1464-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0007-0920

10.1038/sj.bjc.6601730 doi


Angiogenesis Inhibitors--therapeutic use
Animals
Antineoplastic Agents, Phytogenic--therapeutic use
Bridged-Ring Compounds--therapeutic use
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Female
Humans
Mice
Mice, Nude
Neoplasm Transplantation
Ovarian Neoplasms--drug therapy
Paclitaxel--therapeutic use
Taxoids--therapeutic use
Transplantation, Heterologous